Self-deploying vascular occlusion device

ABSTRACT

The present invention provides a cardiac vascular occlusion system which includes inner and outer guide catheters and an occluding member disposed on the inner catheter. The occluding member may be deployed from a compressed to an expanded position to limit retrograde blood flow in a body lumen. The occluding member may be used when injecting a contrast agent into the body lumen.

CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation application of U.S. patentapplication Ser. No. 12/237,121, filed Sep. 24, 2008, which is hereinincorporated by reference in its entirety for all purposes.

TECHNICAL FIELD

The present invention relates to an occlusion device for occluding orrestricting the flow of blood in a vessel, and in particular to anocclusion device that self-deploys when subjected to blood flow in avessel of a patient's vascular system.

BACKGROUND

Cardiac function management systems are used to treat arrhythmias andother abnormal heart conditions. Such systems generally include cardiacleads, which are implanted in or about the heart, for delivering anelectrical pulse to the cardiac muscle, for sensing electrical signalsproduced in the cardiac muscle, or for both delivering and sensing.

During the cardiac lead placement procedure, it often becomes necessaryand/or desirable to inject a contrast agent in the vicinity of thecoronary sinus and then to form an image of the coronary sinus andsurrounding vasculature in order to identify an appropriate vessel forlead placement. For example, a physician may perform a venogramprocedure in which a radiopaque contrast agent is injected in thevicinity of the cardiac sinus, and then an X-ray image of the cardiacsinus is then taken. One difficulty physicians face when injecting acontrast agent in this manner is that retrograde blood flow tends toprematurely disperse the contrast agent such that the images of thedesired blood vessels lack sufficient clarity for a physician tosub-select an appropriate vessel for lead placement. This contrast agentdispersion problem is particularly noticeable in the coronary sinus,which has a relatively large diameter and consequently passes arelatively high volume of blood.

Physicians face similar difficulties when injecting substantiallytransparent fluids (e.g., saline or dextrose) prior to light orultrasound imaging of the vessel, and/or prior to subjecting a vessel tophotodynamic and/or RF/electrical therapy. Such transparent fluids areused to provide an improved pathway or window for energy exposure, butmay be carried away prematurely by blood flow. Further difficulties arefaced by physicians injecting therapeutic agents for intravasculartreatment of a condition. Typically, the therapeutic agent should bemaintained in a specific location or region for at least a minimum timeperiod. However, blood flow tends to carry the therapeutic agent awayfrom the desired site prematurely.

There is a need in the art for a device adapted to occlude blood flow ina vessel to help maintain an injected substance at a target site in thevessel. There is a further need for a device which deploys readily andreliably.

SUMMARY

The present invention, according to one embodiment, is a cardiac leadimplantation system. The system includes an outer catheter having aproximal end and a distal end and an outer tubular wall which defines anouter lumen extending between the proximal and distal ends and an innercatheter having a proximal end and a distal end and an inner tubularwall which defines an inner lumen extending between the proximal anddistal ends, the inner catheter being sized and shaped to pass throughthe outer lumen. A self-deploying occluding member is secured to theinner tubular wall. The occluding member is adapted to self-deploy froma compressed position when disposed within the outer lumen to anexpanded position when positioned beyond the distal end of the outercatheter. The system further includes a cardiac lead for implantation ina coronary vessel, the cardiac lead being adapted to extend througheither the inner or the outer lumen.

According to another embodiment, the present invention is a method fordelivering contrast agent to a coronary vessel in a patient. The methodincludes guiding an outer catheter into the vicinity of the coronaryvessel, the outer catheter having a proximal end and a distal end andincluding an outer tubular wall defining an outer lumen extendingbetween the proximal and distal ends. It further includes guiding aninner catheter through the outer lumen and past the distal end of theouter catheter, the inner catheter having a proximal end and a distalend, and including an inner tubular wall defining an inner lumenextending between the proximal and distal ends, wherein the innercatheter further includes an occluding member secured to the innertubular wall, the occluding member being retained in a compressedposition when disposed within the outer lumen. The occluding member isdeployed to an expanded position by moving either the inner catheter orthe outer catheter longitudinally such that the occluding member ismoved beyond the distal end of the outer catheter and into the expandedposition to restrict retrograde blood flow. A contrast agent isdelivered to the coronary vessel while the occluding member is in theexpanded position.

Another embodiment of the present invention is a device for occluding ablood vessel. The device includes a guide having proximal and distalends and defining at least one lumen adapted to deliver a substance tothe blood vessel, an occluding member including a frame coupled to theguide and a membrane attached to the frame, wherein the occluding memberis adapted to actuate from a compressed position to an expanded positionat least partially in response to blood flow in the blood vessel, and atendon coupled to the guide and extending from the proximal end to nearthe distal end, the tendon having a tendon distal end coupled to theframe and adapted to at least partially actuate the occluding member.

While multiple embodiments are disclosed, still other embodiments of thepresent invention will become apparent to those skilled in the art fromthe following detailed description, which shows and describesillustrative embodiments of the invention. As will be realized, theinvention is capable of modifications in various obvious aspects, allwithout departing from the spirit and scope of the present invention.Accordingly, the drawings and detailed description are to be regarded asillustrative in nature and not restrictive.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a cardiac lead implanted in the vicinity of a patient'scoronary sinus.

FIGS. 2A-2C show a cardiac vascular occlusion system according tocertain embodiments of the present invention.

FIGS. 3A-3B show a cardiac vascular occlusion system according toanother embodiment of the present invention.

FIGS. 4A-4B show schematic views of a cardiac vascular occlusion systemaccording to another embodiment of the present invention.

FIGS. 5A-5B show a cardiac vascular occlusion system according toanother embodiment of the present invention.

FIG. 6 is a flowchart showing a method of using the cardiac vascularocclusion system according to one embodiment of the present invention.

FIGS. 7A-7B shows a cardiac placement system according to one embodimentof the present invention implanted in the vicinity of a patient'scoronary sinus.

While the invention is amenable to various modifications and alternativeforms, specific embodiments have been shown by way of example in thedrawings and are described in detail below. The intention, however, isnot to limit the invention to the particular embodiments described. Onthe contrary, the invention is intended to cover all modifications,equivalents, and alternatives falling within the scope of the inventionas defined by the appended claims.

DETAILED DESCRIPTION

FIG. 1 is a schematic drawing of a cardiac rhythm management system 10including a pulse generator 12 coupled to an lead 14 having a proximalend 16 and a distal end 18. Distal portions of the lead 14 are disposedin the patient's heart 20, which includes a right atrium 22, a rightventricle 24, a left atrium 26, and a left ventricle 28. In theembodiment illustrated in FIG. 1, the distal end 18 of the lead 14 istransvenously guided through the right atrium 22, through the coronarysinus ostium 29, and into a branch of the coronary sinus 31 or greatcardiac vein 33. The illustrated position of the lead 14 may be used forsensing, delivering pacing, and/or defibrillation energy to the leftside of the heart 20, for the treatment of arrhythmias or other cardiacdisorders requiring therapy delivered to the left side of the heart 20.

FIGS. 2A-2C show a vascular occlusion system 30 according to variousembodiments of the present invention. The vascular occlusion system 30includes an outer catheter 32, an inner catheter 34, and an occludingmember 36. The outer catheter has a proximal end 38, a distal end 40,and a lumen 42 extending between the proximal end 38 and the distal end40. The inner catheter 34 also has a proximal end 44, a distal end 46and a lumen 48 extending between the proximal and distal ends 44, 46.The inner catheter 34 is sized and shaped to slide within the lumen 42of the outer catheter 32. According to one embodiment, the innercatheter 34 is a guidewire, which may or may not include an internallumen.

The occluding member 36 is shown in an expanded position in FIGS. 2A-2B,and in a compressed position within the lumen 42 of the outer catheter32 in FIG. 2C. The occluding member 36 is attached to the inner catheter34 and includes a frame portion 52 and a membrane portion 54. The frameportion 52 is configured to allow expansion from the compressed position(FIG. 2C) to the expanded position (FIGS. 2A-2B) upon being deployedfrom the outer catheter 32. The frame portion 52 may be formed in avariety of shapes and from a variety of conventional materials,including stainless steel, nitinol, and nickel/titanium alloys, as wellas various shape memory alloys and polymers.

The membrane portion 54 is attached to the frame portion 52 and isconfigured to unfold, inflate, or expand upon deployment from the outercatheter 32 depending on the material used to form the frame portion 52and the membrane portion 54. In one embodiment, the membrane portion 54may be formed from a relatively resilient material, including withoutlimitation a variety of conventional polymeric materials as well as thematerials used to form the frame portion 52, such that the membraneportion 54 tends to block and/or re-circulate blood. For example, therelatively flat occluding member 36 shown in FIG. 2A may tend to blockfluid flow. In contrast, the concave shape shown in FIG. 2B may tend toredirect and/or re-circulate blood flow in the opposite direction,thereby creating flow turbulences and/or eddies to impede normal bloodflow.

In another embodiment, the membrane portion 54 may be formed from a moreelastic polymer such that the membrane portion 54 tends to occlude byinflating. Suitable materials for the membrane portion 54 generallyinclude substantially fluid impermeable materials such as silicone,polyurethane, and other biocompatible thermoplastic polymers. Themembrane portion 54 may also be semi-permeable. In one embodiment, theoccluding member 36 may be formed from a unitary piece of material.

In one embodiment, the occluding member 36 self-expands after deploymentfrom the outer catheter 32. Alternatively, the occluding member 36 couldbe manually deployed through the use of strings, tendons, wires, orother members attached to the occluding member 36 and extending to theproximal ends of the outer and inner catheters 32, 34. Alternatively oradditionally, the occluding member 36 could expand by inflating whenexposed to fluid (e.g., blood) flow.

FIGS. 3A-3B show perspective views of a vascular occlusion system 30according to another embodiment of the present invention. FIG. 3A showsthe system 30 in an expanded configuration, and FIG. 3B shows the system30 in a compressed configuration. As shown in FIGS. 3A-3B, the system 30includes an occluding member 60, which includes a frame 62 and amembrane portion 64. The frame 62 may have a shape and function similarto a conventional stent or embolic protection device, and includesstruts 66 connected at each end to rings 68, 70. The frame 62 provides ascaffolding upon which the membrane portion 64 resides.

The frame 62 may be self-expanding such that the occluding device 60expands upon deploying from the outer catheter 32. Alternatively, theframe 62 may be biased to a compressed position, but may expand inresponse to the force generated by the flow of fluid in the vesselagainst the membrane portion 64. In either case, one or both of therings 68, 70 may slide relative to the inner catheter 34 to facilitatethe expansion and/or compression of the struts 66. In a particularembodiment, ring 70 may slide, while ring 68 may remain fixed to thelead body.

FIGS. 4A-4B show schematic views of a vascular occlusion system 30according to another embodiment of the present invention. As show inFIGS. 4A-4B, the system 30 includes an outer catheter 32, an innercatheter 34, and an occluding member 60. The occluding member 60, whichis coupled to the inner catheter 34, has a frame 62 with rings 68, 70connected by struts 66 and a membrane portion 64 disposed over a portionof the frame 62. As shown, the membrane portion 64 is disposed on adistal portion of the frame 62 (the left-hand side as shown in FIGS. 4Aand 4B), such that the occluding member 60 is configured to occludeblood flowing in the same direction as the insertion path of thevascular occlusion system 30 (e.g., coronary artery applications).According to another embodiment, the membrane portion 64 is disposed ona proximal portion of the frame 62, such that the occluding member 60 isconfigured to occlude blood flowing in the opposite direction of theinsertion path (e.g., coronary vein applications). In one embodiment,the occluding member 60 is held in a collapsed position (see FIG. 4B) bythe outer catheter 32 and is deployed by retracting the outer catheter32 and allowing blood flow to impart a deploying force on the membraneportion 64.

In another embodiment, the vascular occlusion system 30 includes a wire,tendon, or stylet 71 (or similar device), which is adapted to extendthrough or along the inner catheter 34 and couple to the ring 70. Inthis embodiment, the ring 70 is configured to slide along the innercatheter 34 to facilitate the expansion (see FIG. 4A) or compression(see FIG. 4B) of the occluding member 60. The stylet 71 may be used topush or pull the ring 70 along the inner catheter 34. In thisembodiment, the ring 68 is fixed, such that motion of the ring 70proximally causes a radial expansion of the struts 66, which in turncauses an expansion or opening of the membrane portion 64. Once themembrane portion 64 opens slightly, blood flow in the vessel will imparta force on the membrane portion 64 causing full deployment.

In one embodiment, the ring 70 is fixed with respect to the innercatheter 34 and the stylet 71 is coupled to the ring 68, which may slidedistally to cause a radial expansion of the struts 66. In oneembodiment, the inner catheter 34 includes a port or opening, which isdisposed between the locations of the rings 68, 70 while the occludingmember 60 is in the expanded position (see FIG. 4A). This opening may beused to inject a contrast agent or other substance through a lumen ofthe inner catheter 34 to within the occluded vessel. The stylet 71 maybe located in the same lumen of the catheter 34 that is used to inject acontrast agent or other substance, or it may be located in a separatelumen. In one embodiment, the catheter 34 includes two or more coaxiallumens, and the stylet 71 is located in an outer lumen located, forexample, between two layers of the catheter 34.

In one embodiment, the vascular occlusion system 30 does not include theouter catheter 32, but instead includes only a single guide or catheter34. In this embodiment, the tendon or stylet 71 is operable to causeaxial movement of one of the rings 68, 70, with respect to the other. Inthis embodiment, the occluding member 60 can be deployed by applying aforce to the stylet 71 to cause one of the rings 68, 70 to move towardthe other, which causes a radial expansion of the struts 66. In anotherembodiment, occluding member 60 does not include the rings 68, 70. Inthis embodiment, the stylet 71 is coupled to a portion of the frame 62and the occluding member 60 is deployed by using the stylet 71 to effectan axial compression and corresponding radial expansion of the frame 62.

This radial expansion of the struts 66 causes an opening of the membraneportion 64. Blood flow in the vessel then impacts the membrane portion64 and causes full deployment. This deployment of the membrane portion64 causes at least a partial occlusion of blood flow in the vessel. Acontrast agent (or other substance) can then be injected into the vesselthrough a lumen of the catheter 34. The occluding member 60 can becollapsed by using the stylet 71 to expand the distance between therings 68, 70, which in turn causes the struts 66 and thus the membraneportion 64 to move adjacent the catheter 34. In one embodiment, theframe 62 is predisposed to hold the membrane portion 64 against thecatheter 34.

FIGS. 5A-5B show perspective views of a vascular occlusion system 30according to another embodiment of the present invention. As shown inFIGS. 5A-5B, the frame 62 again includes a plurality of struts 66 whichform a stent-like shape. In this embodiment, as compared to that ofFIGS. 3A-3B, the distal end of the frame 62 is not crimped down orsecured to the inner catheter 34 when expanded. The proximal end of theframe 62 is attached to the inner catheter 34, for example, by a ring68, which may be movable or remain fixed relative to the inner catheter34. In either case, the frame self-expands, or expands under the forcegenerated by blood flow against the membrane 64, to occlude the desiredvessel, and may be compressed by sliding outer catheter 32 distally overthe occluding member 60.

The occluding member 36 or 60 may also be adjustable along variouspositions on the inner catheter 34. In one embodiment, the occludingmember 36 or 60 is disposed proximally to the distal end of the innercatheter 34. For example, the occluding member 36 or 60 may bepositioned between about 2 cm and about 5 cm from the distal end of theinner catheter 34. One benefit of setting the occluding member 36 or 60back from the distal end of the inner catheter 34 is that when acontrast agent is injected while the occluding member 36 or 60 isexpanded, it may take longer for the contrast agent to flow past theoccluding member 36 or 60.

In the expanded configuration, the occluding member 36 or 60 may eitherpartially or fully occlude the vessel depending on the diameter of thevessel as compared to the diameter of the occluding member 36 or 60. Inembodiments in which only partial occlusion occurs, some blood flow maycontinue past the occluding member 36 or 60 and through the vessel.Likewise, injected contrast agent may flow past the occluding member 36or 60 such that vessels disposed proximally of the occluding member 36or 60 may be imaged. One potential benefit of utilizing a self-expandingor flow-expanding occluding member 36 or 60 is that the risk ofinjuring, perforating, and/or bursting a vessel when the occludingmember 36 or 60 expands is minimized as compared to a balloon-typemember, which may run the risk of being overfilled during use.

FIG. 6 is a flowchart showing a method of using the vascular occlusionsystem 30 shown in FIG. 2 according to one embodiment of the presentinvention. As show, the outer catheter 32 is first directed into apatient's superior vena cava and through the opening of the coronarysinus 29 (block 80). The inner catheter 34 is then guided through theouter catheter 32 until the occluding member 36 is positioned justproximally of the distal end of the outer catheter 32 (block 82) asshown in FIG. 7A. when a clinician decides to image the coronary sinus29 and surrounding vessels, the occluding member 36 is deployed distallyout of the outer catheter 32 by relative movement between the outercatheter 32 and the inner catheter 34 (“84”). The occluding member 36then expands as shown in FIG. 7B by one of the mechanisms describedabove in reference to specific embodiments of the present invention.

Upon expansion, the occluding member 36 limits retrograde blood flow (inthe direction of the illustrated arrow) out of the coronary sinus. Inthe illustrated embodiment, the occluding member 36 may reflect theblood flow to create counter-currents (e.g. turbulence or eddies), whichin turn, limits retrograde blood flow.

In one embodiment, the occluding member does not necessarily completelyprohibit fluid flow, but rather permits a limited volume of fluid toflow proximally of the occluding member. This may allow sufficientquantities of contrast agent to flow proximally of the occluding memberto image vessels in that area. It may also reduce risks associated withover-pressurization of the coronary sinus. After deploying the occludingmember 36, contrast agent may be injected distally of the occludingmember 36 through the inner catheter 34 (block 86). As previously noted,the inner catheter 34 may extend several centimeters past the occludingmember 36 to increase the dwell time of the contrast agent in the vessel38.

During and/or after injecting the contrast agent into the vessel 38, aclinician may image the patient's great cardiac vein region usingconventional imaging techniques. The clinician may then utilize theresulting images to sub-select a vessel for subsequent vascularocclusion (block 88). The occluding member 36 is then withdrawn backinto the outer catheter 32 (or the outer catheter is forwardly over theoccluding member 36) and into the compressed position (block 90).

After the inner catheter 34 and/or outer catheter 32 is directed intothe sub-selected vessel (block 92), a cardiac lead 14 may be guidedthrough either the inner catheter 32 or outer catheter 34 and implantedin the desired vessel (block 94) as shown in FIG. 1. Alternatively, aguidewire may be placed in the sub-selected vessel and the lead 14subsequently implanted. At times, it may become necessary or desirablefor the clinician to perform a second imaging procedure aftersub-selecting a particular vessel to further facilitate vascularocclusion.

Although certain Figures are directed to the use of occluding members tofacilitate cardiac vascular occlusion, other applications of suchoccluding members are also within the scope of the present invention.Generally speaking, the occluding member of various embodiments of thepresent invention may be suitable for use in conjunction with cathetersand/or other percutaneous devices that are placed in vessels (e.g.arteries, veins, arterioles, venules, capillaries) or other portions ofthe circulatory system in order to occlude blood flow. For example, theoccluding member may be positioned on a guidewire, IVUS Catheter, OCTcatheter, or a photodynamic catheter to occlude blood flow during theinfusion of a substantially transparent fluid (e.g. saline or dextrose),which replaces blood during the application of imaging or therapeuticenergy (e.g. light, ultrasound, RF, electrical) to a vessel.

In another example, the occluding member may be utilized in conjunctionwith a catheter and/or guidewire to increase the residence time of aninfused bioactive agent (e.g. cells, cell derivatives, pharmacologicalagents) in a vessel. An increased residence time may provide extendedtreatment at the desired location, and/or may localize the treatment atthe desired vessel or tissue site.

Various modifications and additions can be made to the exemplaryembodiments discussed without departing from the scope of the presentinvention. For example, while the embodiments described above refer toparticular features, the scope of this invention also includesembodiments having different combinations of features and embodimentsthat do not include all of the described features. Accordingly, thescope of the present invention is intended to embrace all suchalternatives, modifications, and variations as fall within the scope ofthe claims, together with all equivalents thereof.

1. A method for delivering contrast agent to a coronary vessel in apatient comprising: guiding an outer catheter into the vicinity of thecoronary vessel, the outer catheter having a proximal end, a distal endand an outer tubular wall defining an outer lumen extending between theproximal and distal ends; guiding an inner catheter through the outerlumen, the inner catheter having a proximal end, a distal end, and aninner tubular wall defining an inner lumen extending between theproximal and distal ends, wherein the inner catheter further includes anoccluding member secured to the inner tubular wall, the occluding memberbeing retained in a compressed position when disposed within the outerlumen; deploying the occluding member to an expanded position by movingeither the inner catheter or the outer catheter longitudinally such thatthe occluding member is moved beyond the distal end of the outercatheter and into the expanded position to restrict retrograde bloodflow; and delivering a contrast agent to the coronary vessel while theoccluding member is in the expanded position.
 2. The method of claim 1,wherein the distal end of the inner catheter is guided through thecoronary sinus and distally of the distal end of the outer catheter. 3.The method of claim 1, wherein the contrast agent is delivered to thebody lumen site through a lumen in the inner or outer catheter.
 4. Themethod of claim 1, wherein deploying the occluding member comprisesexposing the occluding member to blood flowing through the coronaryvessel, the blood flow causing the occluding member to expand.
 5. Themethod of claim 1, wherein the occluding member further comprises a ringthat is operably connected to a stylet, and deploying the occludingmember comprises moving the stylet in an axial direction.
 6. The methodof claim 1, wherein the occluding member has a flat shape configured toblock blood flow.
 7. The method of claim 1, wherein the occluding memberhas a concave shape configured to redirect blood flow in an oppositedirection.
 8. The method of claim 1, further comprising sub-selecting avessel for cardiac lead placement.
 9. The method of claim 8, furthercomprising withdrawing the occluding member and directing the innercatheter into the sub-selected vessel.
 10. The method of claim 9,further comprising guiding a cardiac lead through the inner catheter andinto the sub-selected vessel.
 11. A method for delivering contrast agentto a coronary vessel in a patient comprising: guiding an outer catheterinto the vicinity of the coronary vessel, the outer catheter having aproximal end, a distal end and an outer tubular wall defining an outerlumen extending between the proximal and distal ends; guiding an innercatheter through the outer lumen, the inner catheter having a proximalend, a distal end and an inner tubular wall defining an inner lumenextending between the proximal and distal ends, wherein the innercatheter further includes an inflatable occluding member secured to theinner tubular wall; deploying the inflatable occluding member to anexpanded position by inflating the inflatable occluding member such thatthe inflatable occluding member restricts retrograde blood flow; anddelivering a contrast agent to the coronary vessel while the inflatableoccluding member is in the expanded position.
 12. The method of claim11, further comprising guiding a cardiac lead through either the inneror outer lumen for implantation in the vicinity of the patient's heart.13. The method of claim 11, wherein the distal end of the inner catheteris guided through the coronary sinus and distally of the distal end ofthe outer catheter.
 14. The method of claim 11, wherein the contrastagent is delivered to the body lumen site through a lumen in the inneror outer catheter.
 15. A device for occluding a blood vessel, the devicecomprising: a guide having a proximal end, a distal end and at least onelumen extending therebetween adapted to deliver a substance to the bloodvessel; an occluding member including a frame coupled to the guide and amembrane attached to the frame, wherein the occluding member is adaptedto actuate from a compressed position to an expanded position at leastpartially in response to blood flow in the blood vessel; and a tendoncoupled to the guide and extending from the proximal end to near thedistal end, the tendon having a tendon distal end coupled to the frameand adapted to at least partially actuate the occluding member.
 16. Thedevice of claim 15, wherein the tendon is disposed within the lumen orwithin a separate lumen in the guide.
 17. The device of claim 15,wherein the frame includes a first ring, a second ring, and a pluralityof struts connecting the first and second rings, and further wherein thetendon distal end is coupled to one of the first and second rings. 18.The device of claim 17, wherein the first ring is axially fixed withrespect to the inner guide and the second ring is slidably coupled tothe inner guide, and further wherein the tendon is coupled to the secondring.
 19. The device of claim 15, wherein the inner guide comprises aguidewire or a catheter.
 20. The device of claim 15, wherein the innerguide is selected from the group consisting of an intravascularultrasound device, an optical coherence tomography device, aphotodynamic therapy device and an ablation device.